FDA makes management changes

Former Dartmouth Medical School dean Stephen Spielberg has been named the deputy commissioner for medical products and tobacco, a newly-created position at the FDA. In a letter, Commissioner Margaret Hamburg said the reorganization "more accurately reflect the agency's responsibilities, subject matter expertise and mandates in an ever more complex world, where products and services do not fit into a single category." Spielberg will oversee for drugs, medical devices, biological products and tobacco. Additionally, current CDER Office of Compliance director Deborah Autor will become Deputy Commissioner for Global Regulatory Operations and Policy. She'll be tasked with addressing global regulatory issues. Article | Report

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.